SHL
Fiscal year ends September Quarters are offset from the calendar — Q1 is Oct–Dec

Siemens Healthineers AG is a medical technology company providing a comprehensive portfolio of products, services, and solutions for the complete care continuum. The company operates across three main business segments: Imaging, Diagnostics, and Therapy. Its product lines include computed tomography (CT), magnetic resonance imaging (MRI), ultrasound, and X-ray systems, as well as in-vitro diagnostics and clinical chemistry systems. In the therapy segment, the company offers radiation therapy systems, including proton therapy and adaptive radiotherapy, as well as interventional oncology and robotics solutions. Siemens Healthineers serves healthcare providers, hospitals, and research institutions globally, focusing on non-communicable diseases such as cancer, cardiovascular disease, and neurodegenerative disorders. The company integrates artificial intelligence and digital health technologies into its offerings to support clinical decision-making and personalized treatment. It was spun off from Siemens in 2016 and listed on the Frankfurt Stock Exchange in 2018. The company’s history includes the development of early medical X-ray devices and the integration of Varian’s radiation therapy technologies.

Summarised from the company's own disclosures, fiscal year ended Oct 2026

Industry Medical Devices Homepage siemens-healthineers.com
Sector Healthcare IR page siemens-healthineers.com/investor-relations
Tags
imaging, diagnostics, radiation therapy, proton therapy, ultrasound, magnetic resonance imaging, computed tomography, in-vitro diagnostics, clinical chemistry, robotics, artificial intelligence, oncology, Varian, ProBeam, Ethos, Millennium, Shape, Healthcare AI, Patient Twinning, Precision Therapy
Press page —

Metrics

Valuation  
Market cap € 44.15B
Market cap (USD) $ 54.016B
P/E 21.77
PEG 12.77
P/BV 2.30
P/S 1.89
P/OCF 12.50
P/FCF —
Dividend yield —
Turnover / mcap —
Returns  
ROE 11.8%
ROI 11.9%
ROIC 11.9%
Profit margin 9.2%
Growth  
Revenue growing Yes
Profits growing Yes
Revenue up 3y No
Revenue up 5y No
Earnings growth 3y (net profit CAGR) 1.7%
Quality  
Profitable Yes
Margin expanding Yes
Buying back stock No
Diluting (TTM) No
Debt/Equity —
Podcast bulls (TTM) Sign up
Podcast bears (TTM) Sign up
Podcast sentiment (TTM) Sign up
Podcast sentiment % (TTM) Sign up
News sentiment (TTM) 0
Quality score 23.5%
Insiders  
Buys, 1w Sign up
Buys, 1m Sign up
Buys, 1y Sign up
Sells, 1w Sign up
Sells, 1m Sign up
Sells, 1y Sign up

Sign up to see this company's insider trades

Figure FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2018 FY 2017
Revenue 23.375B 22.363B 21.68B 21.714B 17.997B 14.46B 13.429B 13.677B
Net profit 2.144B 1.942B 1.509B 2.038B 1.727B 1.411B 1.265B 1.379B

Figure FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2018 FY 2017
Share price 46.02 53.86 48 44.28 56.18 38.3 — —
Price performance 12m -0.15 0.12 0.08 -0.21 0.47 0.06 — —

Sign up to see institutional holdings

Sign Up

Podcast Mentions

Sign up to see podcast mentions and sentiment

Sign Up

Release of a capital market information Bull 0 Bear 0 Routine

Prompts

Siemens Healthineers AG (ticker SHL), listed in Germany.

ETFs Holding Siemens Healthineers AG

ETF Weight in ETF Shares Market value As of
DTAN 1.30% 5,923 $ 282.293K Nov 17, 2026
TOUS 0.47% 175,623 $ 7.479M Jul 31, 2026
CGIC 0.31% 165,354 $ 8M Nov 16, 2026
RGLO 0.16% 13,908 $ 543.482K Jun 30, 2026
TIER 0.14% 1,175 $ 50.037K Jul 31, 2026
DFSI 0.07% 16,910 $ 819.647K Nov 12, 2026
DFAI 0.07% 253,401 $ 12.283M Nov 12, 2026
DFIC 0.07% 207,928 $ 10.079M Nov 12, 2026
NTSI 0.04% 5,376 $ 210.206K Jun 30, 2026
DFIV 0.04% 193,105 $ 9.36M Nov 12, 2026
AVDE 0.03% 117,911 $ 5.677M Nov 16, 2026
DXIV 0.03% 1,304 $ 63.206K Nov 12, 2026
DFAX 0.02% 52,705 $ 2.555M Nov 12, 2026
AVSD 0.01% 675 $ 32.501K Nov 16, 2026